Biopharmaceuticals Embrace Laboratory Automation: A Market Overview

16 Oct 2023

 Laboratory Automation Market

As healthcare embraces modern technologies such as robotics, artificial intelligence (AI), and data analytics, automation has entered the labs. Biopharmaceuticals are set to transform their diagnostic operations, enhancing precision lab productivity through automation.

What is lab automation?

Laboratory automation is the use of advanced technology and robotic systems to automate and streamline laborious laboratory processes such as sample preparation and handling, data analysis, data management, and workflows. The goal of laboratory automation is to enhance efficiency, accuracy, and productivity within scientific research, laboratory diagnostics, and production processes.

Laboratory automation systems involve robotic arms, automated liquid handling systems, sample processing workstations, and data management software. These systems enable high throughput screening, precision medicine, complex data analysis, and development of innovative products and solutions.

Lab Automation Applications

Laboratory automation offers various advantages, including reduced errors, increased lab productivity, cost and space savings, safe working conditions, and lab customization.

Owing to these advantages, lab automation finds applications in various industries, such as pharmaceuticals, biotechnology, clinical diagnostics, environmental testing, food and beverage, forensics, and materials science.

Key players such as Danaher Corporation, Abbott, and Thermo Fisher Scientific, Inc. for fully automated systems, and Eppendorf Group, PerkinElmer Inc., and Waters Corporation for semi-automated systems are the major players in the market.

 Laboratory Automation Industry

Lab Automation Market Landscape

? Laboratory Automation report

According to the BIS Research market intelligence report, the global laboratory automation market was valued at $9.17 billion in 2022 and is anticipated to reach $24.84 billion by 2033, witnessing a CAGR of 9.57% during the forecast period 2023-2033. 

The current landscape of the laboratory automation market is characterized by a dynamic interplay of various stakeholders, technologies, and trends that collectively shape the industry's growth and innovation. This ecosystem encompasses a wide range of components, from technology providers and manufacturers to distributors, end users, regulatory bodies, and industry associations.

Moreover, the integration of artificial intelligence, machine learning, and robotics is further anticipated to lead to smarter and more autonomous laboratories, enabling real-time data analysis, predictive insights, and adaptive experiment design.

Seamless connectivity between instruments, cloud-based data management, and remote monitoring will further improve the way laboratories operate, enhancing collaboration and enabling researchers to focus on complex tasks requiring human expertise.

Despite such exponential market potential, the laboratory automation market faces restraints due to the high capital investment and maintenance costs associated with the adoption and maintenance of lab automation technologies. Moreover, the process of merging new automation technologies within established workflows and infrastructure is very complex, employing lab super technicians and advanced robotics engineers.

Recent Developments Fueling the Lab Automation Market

  1. In January 2023, Aim Lab Automation Technologies signed a distribution agreement with Al Zahrawi Group. Through this agreement, the products of the company would be distributed amongst hospitals, clinics, laboratories, and analytical industries across the U.A.E., Qatar, Bahrain, and Oman markets.
  2. In February 2023, Element Biosciences collaborated with Tecan Group to have its DNA sample preparation automated by Tecan’s Automation Solutions. This collaboration would open access to new technologies as well as increase the credibility of element biosciences.
  3. In February 2023, Thermo Fisher Scientific and Celltrio collaborated to introduce a fully automated cell line automation platform addressing previous scaling-up restraints in biotherapeutics.
  4. In May 2023, Hamilton and BioSero joined forces in a strategic co-marketing agreement focused on optimizing automated liquid handling workflows in laboratories.
  5. In May 2023, Abbott Laboratories launched its GLP Systems Track Laboratory Automation Solution. By utilizing an automated sample delivery track system, the GLP TLA system demonstrates remarkable efficiency by seamlessly processing a total of 900 samples per hour.
  6. In June 2023, Becton, Dickinson and Company introduced the BD FACSDuet Premium Sample Preparation System, an innovative automated device tailored for sample preparation in clinical diagnostics utilizing flow cytometry. This instrument offers a comprehensive "walkaway" workflow solution, enhancing consistency and reproducibility in cellular diagnostics. By incorporating liquid-handling robotics, the BD FACSDuet system fully automates the sample preparation procedure, catering to both in vitro diagnostics (IVD) and customizable tests.


As technologies such as robotics, AI, and data analytics continue to evolve, the road ahead promises even greater integration and penetration of automation, smarter laboratories, and new era of scientific exploration. The lab automation market is also influenced by trends in personalized medicine, stringent regulatory compliance, and growing emphasis on environmental sustainability.

Interested to know more about the growing technologies in your industry vertical? Get the latest market studies and insights from BIS Research. Connect with us at [email protected] to learn and understand more.